RCMI Coordinating Center (RCMI CC) Header Logo

Sandi Kwee, MD, PhD

Title
Faculty RankAssociate Professor
InstitutionUniversity of Hawaii
DepartmentCancer Biology
AddressUniversity of Hawaii Cancer Center
701 Ilalo St
Honolulu HI
Phone8086915466
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Wong LL, Landsittel DP, Kwee SA. Liver Transplantation vs Partial Hepatectomy for Stage T2 Multifocal Hepatocellular Carcinoma <3?cm Without Vascular Invasion: A Propensity Score-Matched Survival Analysis. J Am Coll Surg. 2023 09 01; 237(3):568-577. PMID: 37102575.
      Citations:    Fields:    Translation:Humans
    2. Yee SK, Hernandez BY, Kwee S, Wong LL. Hepatocellular carcinoma in Pacific Islanders: comparison of Pacific Island-born vs. US-born. Hepatoma Res. 2023; 9. PMID: 37035453.
      Citations:    
    3. Kwee SA, Wong LL, Ludema C, Deng CK, Taira D, Seto T, Landsittel D. Target Trial Emulation: A Design Tool for Cancer Clinical Trials. JCO Clin Cancer Inform. 2023 01; 7:e2200140. PMID: 36608311.
      Citations:    Fields:    Translation:Humans
    4. Kwee S, Chen X. Immunotherapy biomarkers for HCC: contemporary challenges and emerging opportunities. Hepatoma Res. 2022; 8. PMID: 36120489.
      Citations:    
    5. Kwee SA, Wong LL, Sato MM, Acoba JD, Rho YS, Srivastava A, Landsittel DP. Transarterial Radioembolization for Hepatocellular Carcinoma with Major Vascular Invasion: A Nationwide Propensity Score-Matched Analysis with Target Trial Emulation. J Vasc Interv Radiol. 2021 09; 32(9):1258-1266.e6. PMID: 34242775.
      Citations: 5     Fields:    Translation:Humans
    6. Kwee SA, Tiirikainen M. Beta-catenin activation and immunotherapy resistance in hepatocellular carcinoma: mechanisms and biomarkers. Hepatoma Res. 2021; 7. PMID: 33553649.
      Citations:    
    7. Rho YS, Pagano I, Wong LL, Kwee SA, Acoba JD. Factors and Survival Implications associated with biopsy of hepatocellular carcinoma. HPB (Oxford). 2021 07; 23(7):1054-1060. PMID: 33229278.
      Citations:    Fields:    Translation:Humans
    8. Xie G, Wang X, Wei R, Wang J, Zhao A, Chen T, Wang Y, Zhang H, Xiao Z, Liu X, Deng Y, Wong L, Rajani C, Kwee S, Bian H, Gao X, Liu P, Jia W. Serum metabolite profiles are associated with the presence of advanced liver fibrosis in Chinese patients with chronic hepatitis B viral infection. BMC Med. 2020 06 05; 18(1):144. PMID: 32498677.
      Citations: 15     Fields:    Translation:Humans
    9. Evangelista EB, Kwee SA, Sato MM, Wang L, Rettenmeier C, Xie G, Jia W, Wong LL. Phospholipids are A Potentially Important Source of Tissue Biomarkers for Hepatocellular Carcinoma: Results of a Pilot Study Involving Targeted Metabolomics. Diagnostics (Basel). 2019 Oct 29; 9(4). PMID: 31671805.
      Citations:    
    10. Zhang Y, Jiang R, Zheng X, Lei S, Huang F, Xie G, Kwee S, Yu H, Farrar C, Sun B, Zhao A, Jia W. Ursodeoxycholic acid accelerates bile acid enterohepatic circulation. Br J Pharmacol. 2019 08; 176(16):2848-2863. PMID: 31077342.
      Citations: 23     Fields:    Translation:HumansAnimalsCells
    11. Wong L, Bozhilov K, Hernandez B, Kwee S, Chan O, Ellis L, LeMarchand L. Underlying liver disease and advanced stage liver cancer are associated with elevated neutrophil-lymphocyte ratio. Clin Mol Hepatol. 2019 09; 25(3):305-316. PMID: 31001964.
      Citations: 18     Fields:    Translation:HumansCells
    12. Kwee SA, Tiirikainen M, Sato MM, Acoba JD, Wei R, Jia W, Le Marchand L, Wong LL. Transcriptomics Associates Molecular Features with 18F-Fluorocholine PET/CT Imaging Phenotype and Its Potential Relationship to Survival in Hepatocellular Carcinoma. Cancer Res. 2019 04 01; 79(7):1696-1704. PMID: 30760520.
      Citations: 8     Fields:    Translation:HumansCells
    13. Wu EM, Wong LL, Hernandez BY, Ji JF, Jia W, Kwee SA, Kalathil S. Gender differences in hepatocellular cancer: disparities in nonalcoholic fatty liver disease/steatohepatitis and liver transplantation. Hepatoma Res. 2018; 4. PMID: 30687780.
      Citations:    
    14. Wei R, Wang J, Wang X, Xie G, Wang Y, Zhang H, Peng CY, Rajani C, Kwee S, Liu P, Jia W. Clinical prediction of HBV and HCV related hepatic fibrosis using machine learning. EBioMedicine. 2018 Sep; 35:124-132. PMID: 30100397.
      Citations: 23     Fields:    Translation:HumansCells
    15. Nishioka ST, Sato MM, Wong LL, Tiirikainen M, Kwee SA. Clinical and molecular sub-classification of hepatocellular carcinoma relative to alpha-fetoprotein level in an Asia-Pacific island cohort. Hepatoma Res. 2018; 4. PMID: 29376136.
      Citations:    
    16. Kwee SA, Wong L, Chan OTM, Kalathil S, Tsai N. PET/CT with 18F Fluorocholine as an Imaging Biomarker for Chronic Liver Disease: A Preliminary Radiopathologic Correspondence Study in Patients with Liver Cancer. Radiology. 2018 04; 287(1):294-302. PMID: 29315063.
      Citations: 4     Fields:    Translation:Humans
    17. Kwee SA, Lim J, Coel MN. Soft Tissue Response on 18F-Fluorocholine PET/CT in Metastatic Castrate-Resistant Prostate Cancer Treated With 223Ra-Dichloride: A Possible Abscopal Effect? Clin Nucl Med. 2017 Nov; 42(11):868-871. PMID: 28872544.
      Citations: 6     Fields:    Translation:Humans
    18. Wong LL, Reyes RJ, Kwee SA, Hernandez BY, Kalathil SC, Tsai NC. Pitfalls in surveillance for hepatocellular carcinoma: How successful is it in the real world? Clin Mol Hepatol. 2017 Sep; 23(3):239-248. PMID: 28706177.
      Citations: 19     Fields:    Translation:HumansPHPublic Health
    19. Kwee SA, Sato MM, Kuang Y, Franke A, Custer L, Miyazaki K, Wong LL. [18F]Fluorocholine PET/CT Imaging of Liver Cancer: Radiopathologic Correlation with Tissue Phospholipid Profiling. Mol Imaging Biol. 2017 06; 19(3):446-455. PMID: 27787742.
      Citations: 12     Fields:    Translation:HumansCTClinical Trials
    20. Zhang JA, Kwee SA, Wong LL. Late recurrence of hepatocellular carcinoma after liver transplantation. Hepatoma Res. 2017; 3:58-66. PMID: 28966983.
      Citations:    
    21. Kwee SA, Lim J. Metabolic positron emission tomography imaging of cancer: Pairing lipid metabolism with glycolysis. World J Radiol. 2016 Nov 28; 8(11):851-856. PMID: 27928466.
      Citations:    
    22. Okimoto G, Zeinalzadeh A, Wenska T, Loomis M, Nation JB, Fabre T, Tiirikainen M, Hernandez B, Chan O, Wong L, Kwee S. Joint analysis of multiple high-dimensional data types using sparse matrix approximations of rank-1 with applications to ovarian and liver cancer. BioData Min. 2016; 9:24. PMID: 27478503.
      Citations:    
    23. Song MA, Kwee SA, Tiirikainen M, Hernandez BY, Okimoto G, Tsai NC, Wong LL, Yu H. Comparison of genome-scale DNA methylation profiles in hepatocellular carcinoma by viral status. Epigenetics. 2016 06 02; 11(6):464-74. PMID: 27248055.
      Citations: 8     Fields:    Translation:HumansCells
    24. Lee J, Sato MM, Coel MN, Lee KH, Kwee SA. Prediction of PSA Progression in Castration-Resistant Prostate Cancer Based on Treatment-Associated Change in Tumor Burden Quantified by 18F-Fluorocholine PET/CT. J Nucl Med. 2016 07; 57(7):1058-64. PMID: 26912444.
      Citations: 9     Fields:    Translation:Humans
    25. Kwee SA, Okimoto GS, Chan OT, Tiirikainen M, Wong LL. Metabolic characteristics distinguishing intrahepatic cholangiocarcinoma: a negative pilot study of (18)F-fluorocholine PET/CT clarified by transcriptomic analysis. Am J Nucl Med Mol Imaging. 2016; 6(1):73-83. PMID: 27069767.
      Citations:    
    26. Zhou K, Wang J, Xie G, Zhou Y, Yan W, Pan W, Che Y, Zhang T, Wong L, Kwee S, Xiao Y, Wen J, Cai W, Jia W. Distinct Plasma Bile Acid Profiles of Biliary Atresia and Neonatal Hepatitis Syndrome. J Proteome Res. 2015 Nov 06; 14(11):4844-50. PMID: 26449593.
      Citations: 21     Fields:    Translation:Humans
    27. Miyazaki KS, Kuang Y, Kwee SA. Erratum to: Changes in Skeletal Tumor Activity on (18)F-choline PET/CT in Patients Receiving (223)Radium Radionuclide Therapy for Metastatic Prostate Cancer. Nucl Med Mol Imaging. 2015 Dec; 49(4):335. PMID: 26550058.
      Citations:    
    28. Kuang Y, Wu L, Hirata E, Miyazaki K, Sato M, Kwee SA. In Reply to von Eyben et al. Int J Radiat Oncol Biol Phys. 2015 Oct 01; 93(2):467-8. PMID: 26383685.
      Citations:    Fields:    Translation:Humans
    29. Kuang Y, Wu L, Hirata E, Miyazaki K, Sato M, Kwee SA. Volumetric modulated arc therapy planning for primary prostate cancer with selective intraprostatic boost determined by 18F-choline PET/CT. Int J Radiat Oncol Biol Phys. 2015 Apr 01; 91(5):1017-25. PMID: 25832692.
      Citations: 11     Fields:    Translation:Humans
    30. Miyazaki KS, Kuang Y, Kwee SA. Changes in Skeletal Tumor Activity on (18)F-choline PET/CT in Patients Receiving (223)Radium Radionuclide Therapy for Metastatic Prostate Cancer. Nucl Med Mol Imaging. 2015 Jun; 49(2):160-4. PMID: 26082811.
      Citations:    
    31. Kwee SA, Wong LL, Hernandez BY, Chan OT, Sato MM, Tsai N. Chronic Liver Disease and the Detection of Hepatocellular Carcinoma by [(18)F]fluorocholine PET/CT. Diagnostics (Basel). 2015; 5(2):189-99. PMID: 26090216.
      Citations:    
    32. Kwee SA, Lim J, Watanabe A, Kromer-Baker K, Coel MN. Prognosis Related to Metastatic Burden Measured by ?8F-Fluorocholine PET/CT in Castration-Resistant Prostate Cancer. J Nucl Med. 2014 Jun; 55(6):905-10. PMID: 24676753.
      Citations: 18     Fields:    Translation:HumansCTClinical Trials
    33. Hernandez BY, Zhu X, Kwee S, Chan OT, Tsai N, Okimoto G, Horio D, McGlynn KA, Altekruse S, Wong LL. Viral hepatitis markers in liver tissue in relation to serostatus in hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev. 2013 Nov; 22(11):2016-23. PMID: 23983238.
      Citations: 2     Fields:    Translation:HumansCells
    34. Song MA, Tiirikainen M, Kwee S, Okimoto G, Yu H, Wong LL. Elucidating the landscape of aberrant DNA methylation in hepatocellular carcinoma. PLoS One. 2013; 8(2):e55761. PMID: 23437062.
      Citations: 62     Fields:    Translation:HumansCells
    35. Kwee SA, Hernandez B, Chan O, Wong L. Choline kinase alpha and hexokinase-2 protein expression in hepatocellular carcinoma: association with survival. PLoS One. 2012; 7(10):e46591. PMID: 23071593.
      Citations: 62     Fields:    Translation:Humans
    36. Kwee SA, Coel MN, Lim J. Detection of recurrent prostate cancer with 18F-fluorocholine PET/CT in relation to PSA level at the time of imaging. Ann Nucl Med. 2012 Jul; 26(6):501-7. PMID: 22549847.
      Citations: 14     Fields:    Translation:HumansCTClinical Trials
    37. Lan BY, Kwee SA, Wong LL. Positron emission tomography in hepatobiliary and pancreatic malignancies: a review. Am J Surg. 2012 Aug; 204(2):232-41. PMID: 22464445.
      Citations: 13     Fields:    Translation:Humans
    38. Kwee S, Song MA, Cheng I, Loo L, Tiirikainen M. Measurement of circulating cell-free DNA in relation to 18F-fluorocholine PET/CT imaging in chemotherapy-treated advanced prostate cancer. Clin Transl Sci. 2012 Feb; 5(1):65-70. PMID: 22376260.
      Citations: 24     Fields:    Translation:HumansCells
    39. Wong LL, Hernandez B, Kwee S, Albright CL, Okimoto G, Tsai N. Healthcare disparities in Asians and Pacific Islanders with hepatocellular cancer. Am J Surg. 2012 Jun; 203(6):726-32. PMID: 22227170.
      Citations: 13     Fields:    Translation:Humans
    40. Brown JD, Kwee S. Pararenal splenosis encountered during the evaluation of a suspected pheochromocytoma. Am J Med Sci. 2010 Nov; 340(5):424-6. PMID: 20724902.
      Citations: 1     Fields:    Translation:Humans
    41. Kwee S, Ernst T. Total choline at 1H-MRS and [18F]-fluoromethylcholine uptake at PET. Mol Imaging Biol. 2010 Aug; 12(4):424-5; author reply 426. PMID: 20458633.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    42. Brown A, Chow D, Murakami S, Goh W, Perreira A, Kwee S, Sil P, Leroy M. Possible gastrointestinal symptoms in a subset of children with autism. Expert Rev Gastroenterol Hepatol. 2010 Apr; 4(2):125-7. PMID: 20350258.
      Citations:    Fields:    Translation:Humans
    43. Kwee SA, Coel MN. Detection of synchronous primary breast and prostate cancer by F-18 fluorocholine PET/CT. Clin Nucl Med. 2010 Feb; 35(2):128-9. PMID: 20090467.
      Citations: 5     Fields:    Translation:Humans
    44. Lin D, Suwantarat N, Kwee S, Miyashiro M. Cushing's syndrome caused by an ACTH-producing large cell neuroendocrine carcinoma of the gallbladder. World J Gastrointest Oncol. 2010 Jan 15; 2(1):56-8. PMID: 21160818.
      Citations:    
    45. Kwee SA, Coel MN, Ly BH, Lim J. (18)F-Choline PET/CT imaging of RECIST measurable lesions in hormone refractory prostate cancer. Ann Nucl Med. 2009 Aug; 23(6):541-8. PMID: 19529978.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    46. Kwee SA, DeGrado T. Prostate biopsy guided by 18F-fluorocholine PET in men with persistently elevated PSA levels. Eur J Nucl Med Mol Imaging. 2008 Aug; 35(8):1567-9; author reply 1570. PMID: 18521597.
      Citations: 13     Fields:    Translation:Humans
    47. Kwee SA, Thibault GP, Stack RS, Coel MN, Furusato B, Sesterhenn IA. Use of step-section histopathology to evaluate 18F-fluorocholine PET sextant localization of prostate cancer. Mol Imaging. 2008 Jan-Feb; 7(1):12-20. PMID: 18384719.
      Citations: 17     Fields:    Translation:Humans
    48. Kwee SA, DeGrado TR, Talbot JN, Gutman F, Coel MN. Cancer imaging with fluorine-18-labeled choline derivatives. Semin Nucl Med. 2007 Nov; 37(6):420-8. PMID: 17920349.
      Citations: 36     Fields:    Translation:Humans
    49. DeGrado TR, Kwee SA, Coel MN, Coleman RE. The impact of urinary excretion of (18)F-labeled choline analogs. J Nucl Med. 2007 Jul; 48(7):1225. PMID: 17607041.
      Citations: 1     Fields:    Translation:Humans
    50. Kwee SA, Ko JP, Jiang CS, Watters MR, Coel MN. Solitary brain lesions enhancing at MR imaging: evaluation with fluorine 18 fluorocholine PET. Radiology. 2007 Aug; 244(2):557-65. PMID: 17581887.
      Citations: 23     Fields:    Translation:Humans
    51. Kwee SA, Wei H, Sesterhenn I, Yun D, Coel MN. Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET. J Nucl Med. 2006 Feb; 47(2):262-9. PMID: 16455632.
      Citations: 61     Fields:    Translation:Humans
    52. Kwee SA, Coel MN, Lim J, Ko JP. Prostate cancer localization with 18fluorine fluorocholine positron emission tomography. J Urol. 2005 Jan; 173(1):252-5. PMID: 15592091.
      Citations: 33     Fields:    Translation:Humans
    53. Liu DM, Kwee SA. Demographic, treatment, and survival patterns for Native Hawaiians with lung cancer treated at a community medical center from 1995 to 2001. Pac Health Dialog. 2004 Sep; 11(2):139-45. PMID: 16281691.
      Citations: 4     Fields:    Translation:Humans
    54. Kwee SA, Coel MN, Lim J, Ko JP. Combined use of F-18 fluorocholine positron emission tomography and magnetic resonance spectroscopy for brain tumor evaluation. J Neuroimaging. 2004 Jul; 14(3):285-9. PMID: 15228773.
      Citations: 13     Fields:    Translation:Humans
    Kwee's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (192)
    Explore
    _
    Co-Authors (11)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

    For technical support please contact support